Shipman opened his lab at UCSF and the Gladstone Institutes in 2019 with a focus on building new molecular technology to help study and treat human disease. Shipman is affiliated with the Bioengineering graduate program at UCSF and UC Berkeley, as well as the Neuroscience and Biomedical Sciences graduate programs at UCSF.
